Evidence map›Paper›PMID 23915746›Full record

ReviewHematology/oncology clinics of North America2013

Breast cancer survivorship issues.

Daniela Stan, Charles L Loprinzi, Kathryn J Ruddy

Abstract readReview
In one paragraph

Review in Hematology/oncology clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Acute effects of taxanes on sub-tissue fluid proportions in patients with breast cancer who underwent taxane-based chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  8. Article
  9. "Peace of Mind" After Mastectomy: A Scoping Review.Annals of surgical oncology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Daniela StanDivision of General Internal Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. stan.daniela@mayo.edu
Charles L Loprinzi
Kathryn J Ruddy
Mayo Clinic · USDana-Farber Cancer Institute · US

Funding

Survivorship research established investigator awardK05CA124477 · NCI · MAYO CLINIC ROCHESTER · PI LOPRINZI, CHARLES L · 2008 to 2012
$777k
NCI NIH HHS CA 124477NCI NIH HHS K05 CA124477
6 · The paper itself

Abstract

Survivors of breast cancer are confronted with a plethora of cancer treatment-related long-term symptoms, the most common being fatigue, hot flashes, sexual dysfunction, arthralgias, neuropathy, and cognitive dysfunction. Survivors of breast cancer also face cancer treatment-related disease states, such as osteoporosis, cardiac dysfunction, obesity, infertility, and secondary cancers. Evidence-based recommendations for screening, prevention, and early intervention should be implemented to improve quality of life and decrease comorbidities in this population.

Indexed as

SurvivorsBreast NeoplasmsComorbidityFemaleHumansQuality of LifeCognitive changesInfertilityMusculoskeletal painNeuropathyOsteoporosisSexual dysfunctionTreatment-related cancersVasomotor symptoms

Identifiers

PMID23915746
PMCPMC3903408
OpenAlexW2119492807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.